In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Activaero gets €15.7mm through its Series A round

Executive Summary

Activaero GMBH (developed controlled breathing devices used to administer inhaled therapeutics) has raised €10.7mm ($16mm) through the closing of its Series A venture round. BioMedInvest led the financing and was joined by VI Partners AG, Abalis Finance, and Vesalius Biocapital. Each investment company will contribute one member to Activaero's board.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies